Abstract
Although most coxsackievirus (CV) infections in humans are mild and frequently asymptomatic, in some individuals more serious manifestations develop, including meningitis, paralysis, encephalitis, type I (insulin-dependent) diabetes mellitus (IDDM), and myocarditis.1–3 Association of particular viral infections with certain diseases usually depends on demonstration of rising antibody titers to the pathogen and a compatible clinical history. In both IDDM and myocarditis, approximately 50% of recently diagnosed patients demonstrate two- to fourfold rises in CV-specific antibodies compared with less than 20% of control patients.2,3 Furthermore, several studies report dramatic increases in new diabetes and myocarditis cases coinciding with known CV epidemics and also demonstrate definite seasonality for these diseases (fall and winter) that correlate remarkably well with the seasonal distribution of Picornavirus infections.2,3 Despite the nearly convincing circumstantial evidence of CV etiology in myocarditis and diabetes, infectious virus is only rarely isolated from patients with active disease.3
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Davis, B. D., Dulbecco, R., Eisen, H. N., Ginsberg, H. S., and Wood, W. B., Jr. (eds.), 1969, Microbiology, Harper & Row, New York.
Huber, S. A., and MacPherson, B. R., 1984, Virus and insulin-dependent diabetes mellitus, in: Immunology of Clinical and Experimental Diabetes (S. Gupta, ed.), pp. 295–327, Plenum, New York.
Woodruff, J. F., 1980, Viral myocarditis: A review, Am. J. Pathol. 101:425–484.
Rekosh, D. M. K., 1977, The molecular biology of picornaviruses, in: The Molecular Biology of Animal Viruses (D. P. Nayak, ed.), pp. 63–110, Dekker, New York.
Paque, R. E., Gauntt, C. J., Nealon, T. J., and Trousdale, M. D., 1978, Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue,J. Immunol. 120:1672–1678.
Huber, S. A., and Lodge, P. A., 1984, Coxsackievirus B-3 myocarditis in Balb/c mice: Evidence for autoimmunity to myocyte antigens, Am. J. Pathol. 116:21–29.
Huber, S. A., Job, L. P., and Woodruff, J. F., 1980, Lysis of infected myofibers by coxsackievirus B-3 immune T lymphocytes, Am. J. Pathol. 98:681–694.
Wong, C. Y., Woodruff, J. J., and Woodruff, J. F., 1977, Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. 1. Model and viral specificity,J. Immunol. 118:1159–1164.
Lutton, C. W., and Gauntt, C. J., 1976, Coxsackievirus B3 infection alters plasma membranes of neonatal skin fibroblasts,J. Virol. 60:294–296.
Woodruff, J. F., and Woodruff, J. J., 1974, Involvement of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease,J. Immunol. 113:1726–1734.
Gatmaitan, B. G., Chason, J. L., and Lerner, A. M., 1970, Augmentation of the virulence of murine coxsackievirus B3 myocardiopathy by exercise,J. Exp. Med. 131:1121–1136.
Adesanya, C. O., Goldberg, A. H., Plear, W. P. C., Thorn, K. A., Young, N. A., and Abelmann, W. H., 1976, Heart muscle after experimental viral myocarditis,J. Clin. Invest. 57:569–575.
Woodruff, J. F., Wong, C. Y., and Woodruff, J. J., 1977, Cytotoxic T cells in coxsackieviral disease, in: Immune Effector Mechanisms in Disease (M. E. Weksler, S. O. Litwin, R. R. Riggio, and G. W. Siskind, eds.), pp. 207–237, Grune & Stratton, New York.
Huber, S. A., and Job, L. P., 1983, Cellular immune mechanisms in coxsackievirus group B, type 3 induced myocarditis in Balb/c mice, in: Myocardial Injury (J.J. Spitzer, ed.), pp. 491–508, Plenum, New York.
Yoon, J. W., Onodera, T., Jenson, A. B., and Notkins, A. L., 1978, Virus induced diabetes mellitus. XI. Replication of Coxsackie B3 virus in human pancreatic beta cell cultures, Diabetes 27:778–781.
Craighead, J. E., 1980, Experimental models of juvenile onset (insulin-dependent) diabetes mellitus, Monog. Pathol. 21:166–176.
Buschard, K., Rygaard, J., and Lund, E., 1976, The inability of diabetogenic virus to induce diabetes mellitus in athymic (nude) mice, Acta Pathol. Microbiol. Scand. [C] 84:299–303.
Huber, S. A., Babu, P. G., and Craighead, J. E., 1985, Genetic influences on the immunologic pathogenesis of encephalomyocarditis (EMC) virus-induced diabetes mellitus, Diabetes 34:1186–1190.
Hashimoto, I., and Tomatsu, T., 1978, Myocardial changes after infection with Coxsackie virus B3 in nude mice, Br. J. Exp. Pathol. 59:13–20.
Khatib, R., Khatib, G., Chason, J. L., and Lerner, A. M., 1983, Alterations in coxsackievirus B4 heart muscle disease in ICR Swiss mice by anti-thymocyte serum,J. Gen. Virol. 64:231–236.
Robinson, J. A., O’Connell, J. B., Roeges, L. M., Major, E. O., and Gunnar, R. M., 1981, Coxsackie B3 myocarditis in athymic mice, Proc. Soc. Exp. Biol. Med. 166:80–91.
Babu, P. G., Huber, S. A., and Craighead, J. E., 1986, Contrasting features of T lymphocytes mediated diabetes in encephalomyocarditis virus infected Balb/cBy and Balb/c CUM mice, Am. J. Pathol. 124:193–198.
Deguchi, H., Kitaura, Y., Morita, H., Kotaka, M., and Kawamura, K., 1985. Cell-mediated immunity in Coxsackie B3 virus myocarditis in mice. In situ characterization by monoclonal antibody of mononuclear cell infiltrates, in: Myocarditis and related disorders (M. Sekiguchi, E. G.J. Olsen, and J. F. Goodwin, ed.), pp. 221–227, Springer-Verlag, Tokyo.
Guthrie, M., Lodge, P. A., and Huber, S. A., 1984, Cardiac injury in myocarditis induced by coxsackievirus group B, type 3 induced myocarditis in Balb/c mice is mediated by Lyt 2+ cytolytic lymphocytes, Cell. Immunol. 88:558–567.
Waldor, M. K., Sriram, S., Hardy, R., Herzenberg, L. A., Herzenberg, L. A., Lancer, L., Lim, M., and Steinman, L., 1985, Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker, Science 227:415–417.
Cantor, H., and Boyse, E. A., 1975, Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly + cells in the generation of killer activity,J. Exp. Med. 141:1390–1405.
Estrin, M., Herzum, M., Lodge, P. A., and Huber, S. A., 1987, Coxsackievirus B3-induced myocarditis: Autoimmunity is L3T4 + T helper cell and IL-2 independent in Balb/c mice, Am. J. Pathol. 127:335–341.
Gauntt, C. J., Trousdale, M. D., LaBadie, D. R. L., Paque, R. E., and Nealon, T., 1979, Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice,J. Med. Virol. 3: 207–220.
Huber, S. A., and Job, L. P., 1983, Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3, Infect. Immun. 39:1419–1427.
Estrin, M., Smith, C., and Huber, S. A., 1986, Antigen specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3, Am. J. Pathol. 125:578–584.
Chensue, S. W., Kunkel, S. L., Higashi, G. I., Ward, P. A., and Boros, D. L., 1983, Production of superoxide anion, prostaglandins and hydroxyeicosatetraenoic acids by macrophages from hypersensitivity-type (Schistosoma mansoni egg) and foreign body-type granulomas, Infect. Immun. 42:1116–1125.
Berke, G., and Amos, D. B., 1973, Mechanisms of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity, Transplant. Rev. 17:71–121.
Ferluga, J., and Allison, A. C., 1975, Cytotoxicity of isolated plasma membranes from lymph node cells, Nature (Lond.) 255:708–710.
Ferluga, J., and Allison, A. C., 1974, Observations on the mechanism by which T-lymphocytes exert cytotoxic effects, Nature (Lond.) 250:673–675.
Granger, G. A., and Williams, T. W., 1968, Lymphocyte cytotoxicity in vitro: Activation and release of a cytotoxic factor, Nature (Lond.) 218:1253–1254.
Notkins, A. L., Onodera, T., and Prabhakar, B., 1984, Virus-induced autoimmunity, in: Concepts in Viral Pathogenesis (A. L. Notkins, and M. B. A. Oldstone, eds.), pp. 210–215, Springer-Verlag, New York.
Maisch, B., 1984, Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute myocarditis and congestive cardiomyopathy, in: Cardiology (E. I. Chazov, V. N. Smirnov, and R. G. Oganov, eds.), pp. 1327–1338, Plenum, London.
Huber, S. A., Lyden, D. C., and Lodge, P. A., 1985, Immunopathogenesis of experimental coxsackievirus induced myocarditis: Role of autoimmunity, Herz 10:1–10.
Wolfgram, L. J., Beisel, K. W., Herskowitz, A., and Rose, N. R., 1986, Variations in the susceptibility to coxsackievirus B3-induced myocarditis among different strain of mice, J. Immunol. 136:1846–1852.
Huber, S. A., and Lodge, P. A., 1986, Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice, Am. J. Pathol. 122:284–291.
Gauntt, C. J., Gomez, P. T., Duffey, P. S., Grant, J. A., Trent, D. W., Witherspoon, S. M., and Paque, R. E., 1984, Characterization and myocarditis capabilities of coxsackievirus B3 variants in selected mouse strains,J. Virol. 52:598–605.
Stewart, W. E., 1979, The Interferon System, Springer-Verlag, New York.
Biron, C. A., and Welsh, R. M., 1982, Blastogenesis of natural killer cells during viral infections in vivo,J. Immunol. 129:2788–2796.
Godney, E. K., and Gauntt, C. J., 1987, Murine Natural Killer cells limit coxsackievirus B3 replication,J. Immunol. 139:913–918.
Huber, S. A., Job, L. P., and Woodruff, J. F., 1981, Sex related differences in the pattern of coxsackievirus B-3 induced immune spleen cell cytotoxicity against virus infected myofîbers, Infect. Immun. 32:68–73.
Klinkert, W. E. F., LaBadie, J. H., O’Brien, J. P., Beyer, C. F., and Bowers, W. E., 1980, Rat dendritic cells function as accessory cells and control the production of a soluble factor for mitogenic responses of T lymphocytes, Proc. Natl. Acad. Sci. USA 77:5414–5423.
Leszczynsky, D., Renkonen, R., and Hayry, P., 1985, Turnover of dendritic cells in rat heart, Scand.J. Immunol. 22:351–355.
Basham, T. Y., and Merigan T. C., 1983, Recombinant interferon-7 increases HLA-DR synthesis and expression,J. Immunol. 130:1492–1494.
Rager-Zisman, B., and Allison, A. C., 1973, The role of antibody and host cells in the resistance of mice against infection by Coxsackie B-3 virus,J. Gen. Virol. 19:329–338.
Woodruff, J. F., 1979, Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B3 replication in target organs: Evidence for involvement of mononuclear inflammatory cells in host defense,J. Immunol. 123:31–36.
Bottazzo, G. F., Dean, B. M., McNally, J. M., Mackay, E. H., Swift, P. G., and Gamble, D. R., 1985, In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis, N. Engl. J. Med. 313:353–360.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Huber, S.A. (1988). The Role of Immune Mechanisms in Pathogenesis. In: Bendinelli, M., Friedman, H. (eds) Coxsackieviruses. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0247-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0247-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0249-1
Online ISBN: 978-1-4757-0247-7
eBook Packages: Springer Book Archive